AXDX stock news

Our previous bearish article on Accelerate Diagnostics (AXDX) proved to be dead-on accurate on the poor utilization of the Pheno system due to a lack of hospita Read more
TUCSON, Ariz., Jan. 13, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter and year ending December 31, 2019. Highlights for the fourth quarter and full-year 2019 are presented below. 2019 Fourth Quarter and… Read more
TUCSON, Ariz., Dec. 4, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that Lawrence Mehren will retire from the company. Jack Phillips, the company's Chief Operating Officer, has been unanimously appointed by the board to the position, effective February… Read more
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) announced today that Louise Francesconi has been appointed to the company's Board of Directors. Ms…. Read more
Accelerate Diagnostics (NASDAQ:AXDX) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report released on Thursday, ValuEngine reports. A number of other equities research analysts also recently commented on the company. Piper Jaffray Companies decreased their target price on Accelerate Diagnostics from $22.00 to $19.00 and set […] Read more
TUCSON, Ariz., Nov. 4, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that Roland Diggelmann has been appointed to its Board of Directors. "On behalf of the entire board, I am delighted to welcome Roland to Accelerate Diagnostics," commented John… Read more
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes. Read more
White Diamond’s proprietary diligence identified new info that suggests Accelerate Diagnostic's (AXDX) Pheno system is only a niche product. The Pheno system is Read more
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2019 Results Earnings Conference Call May 09, 2019 04:30 PM ET Company Participants Laura Pierson - IR Lawrence Me Read more
AXDX earnings call for the period ending March 31, 2019. Read more
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 6.98% and -17.57%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT